scholarly journals Characterization of Patient Activation, Clinical Assessments, and Patient Reported Outcomes in T2DM Patients

2018 ◽  
Vol 21 ◽  
pp. S77
Author(s):  
L Lamerato ◽  
Y Harris ◽  
A Bissoonauth ◽  
CA Patel ◽  
M Durkin ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Patient Activation ◽  
Clinical Assessments ◽  
Patient Reported

Preoperative patient activation is predictive of improvements in patient-reported outcomes following minimally invasive lumbar decompression

2020 ◽  
Vol 29 (9) ◽  
pp. 2222-2230
Author(s):  
Nathaniel W. Jenkins ◽  
James M. Parrish ◽  
Shruthi Mohan ◽  
Cara E. Geoghegan ◽  
Caroline N. Jadczak ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Patient Reported Outcomes ◽  
Patient Activation ◽  
Lumbar Decompression ◽  
Patient Reported ◽  
Preoperative Patient

An interdisciplinary intensive outpatient pain program is associated with improved patient activation and key outcomes

2020 ◽  
Vol 10 (5) ◽  
pp. 307-318
Author(s):  
Barbara K Bujak ◽  
Christine E Blake ◽  
Paul F Beattie ◽  
Shana Harrington ◽  
Courtney M Monroe ◽  
...  
Keyword(s):  
Outcome Measures ◽  
Patient Reported Outcomes ◽  
Rating Scale ◽  
Patient Activation ◽  
Persistent Pain ◽  
Outpatient Program ◽  
Patient Reported ◽  
Patient Activation Measure ◽  
Intensive Outpatient Program ◽  
Intensive Outpatient

Aim: To examine the change in the Patient Activation Measure and physical and psychosocial outcome measures in a military interdisciplinary intensive outpatient program for persistent pain. Materials & methods: Pre- and post-intervention measures, which were also stratified by gender and baseline activation, included patient-reported outcomes and physical function assessment, obtained from 2017 to 2018 program database. Results: The majority of the participants were male (70.9%), with an average age of 29.18 years and pain duration of 4.78 years (n = 103). Patient activation, majority of the patient reported outcomes and functional assessments improved in the overall sample with fewer changes in females on the Defense and Veterans Pain Rating Scale. Conclusion: Improvements were noted on the Patient Activation Measure and majority of the other outcome measures suggesting that service members with persistent pain at any level of patient activation or baseline function, may benefit from an intensive outpatient program.

scholarly journals Cancer follow-up supported by patient-reported outcomes in patients undergoing intended curative complex surgery for advanced cancer

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Sissel Ravn ◽  
Henriette Vind Thaysen ◽  
Victor Jilbert Verwaal ◽  
Mette Møller Soerensen ◽  
Jonas Funder ◽  
...  
Keyword(s):  
Advanced Cancer ◽  
Fixed Effects ◽  
Patient Reported Outcomes ◽  
Patient Activation ◽  
University Hospital ◽  
Mixed Effect ◽  
Patient Reported ◽  
Complex Surgery ◽  
Over Time

Abstract Background and aim Patient activation (PA) and Patient Involvement (PI) are considered elements in good survivorship. We aimed to evaluate the effect of a follow-up supported by electronic patient-reported outcomes (ePRO) on PA and PI. Method From February 2017 to January 2019, we conducted an explorative interventional study. We included 187 patients followed after intended curative complex surgery for advanced cancer at two different Departments at a University Hospital. Prior to each follow-up consultation, patients used the ePRO to screen themselves for clinical important symptoms, function and needs. The ePRO was graphically presented to the clinician during the follow-up, aiming to facilitate patient activation and involvement in each follow-up. PA was measured by the Patient Activation Measurement (PAM), while PI was measured by five indicator questions. PAM and PI data compared between (− ePRO) and interventional (+ ePRO) consultations. PAM data were analysed using a linear mixed effect regression model with intervention (yes/no) and time along with the interaction between them as categorical fixed effects. The analyses were further adjusted for time (days) since surgery. Results According to our data, ePRO supported consultations did not improve PA. The average mean difference in PAM score between + ePRO and − ePRO consultations were − 0.2 (95% confidence interval − 2.6; 2.2, p = 0.9). There was no statistically significant improvement in PAM scores over time in neither + ePRO nor − ePRO group (p = 0.5). Based on the five PI-indicator questions, the majority of all consultations were evaluated as “some, much or very much” involved in consultation; providing a wider scope of dialogue, encouraged patients to ask questions and share their experiences and concerns. Nevertheless, another few patients reported not to be involved at all in the consultations. Conclusion We did not demonstrate evidence for ePRO supported consultations to improve patient activation, and patient activation did not improve over time. Our results generate the hypotheses that factors related to ePRO supported consultation had the potential to support PI by offering a wider scope of dialogue, and encourage patients to ask questions and share their experiences and concerns during follow-up.

Characterization of Patient-Reported Outcomes in Moderate to Severe Psoriasis

Dermatology ◽  
2011 ◽  
Vol 223 (1) ◽  
pp. 80-86 ◽  
Author(s):  
Stefanie Krenzer ◽  
Marc Radtke ◽  
Karlheinz Schmitt-Rau ◽  
Matthias Augustin
Keyword(s):  
Patient Reported Outcomes ◽  
Severe Psoriasis ◽  
Patient Reported

scholarly journals A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities

2022 ◽  
Vol 17 (1) ◽  
Author(s):  
Jacqueline Montes ◽  
Katy J. Eichinger ◽  
Amy Pasternak ◽  
Cara Yochai ◽  
Kristin J. Krosschell
Keyword(s):  
Virtual Environment ◽  
Patient Reported Outcomes ◽  
Neuromuscular Disorders ◽  
Patient Reported ◽  
Remote Assessment ◽  
Disease Impact ◽  
Clinical Outcome Assessments ◽  
And Function ◽  
Patient Burden

AbstractRecent advances in technology and expanding therapeutic opportunities in neuromuscular disorders has resulted in greater interest in and development of remote assessments. Over the past year, the rapid and abrupt COVID-19 shutdowns and stay-at-home orders imposed challenges to routine clinical management and clinical trials. As in-person services were severely limited, clinicians turned to remote assessments through telehealth to allow for continued care. Typically, disease-specific clinical outcome assessments (COAs) for neuromuscular disorders (NMD) are developed over many years through rigorous and iterative processes to fully understand their psychometric properties. While efforts were underway towards developing remote assessments for NMD before the pandemic, few if any were fully developed or validated. These included assessments of strength, respiratory function and patient-reported outcomes, as well as wearable technology and other devices to quantify physical activity and function. Without many choices, clinicians modified COAs for a virtual environment recognizing it was not yet known how they compared to standard in-person administration. Despite being able to quickly adapt to the demands of the COVID-19 pandemic, these experiences with remote assessments uncovered limitations and opportunities. It became clear that existing COAs required modifications for use in a virtual environment limiting the interpretation of the information gathered. Still, the opportunity for real-world evaluation and reduced patient burden were clear benefits to remote assessment and may provide a more robust understanding and characterization of disease impact in NMD. Hence, we propose a roadmap navigating an informed post-pandemic path toward development and implementation of safe and successful use of remote assessments for patients with NMD.

scholarly journals Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment

2021 ◽  
Author(s):  
Agnieszka Lemanska ◽  
Karen Poole ◽  
Ralph Manders ◽  
John Marshall ◽  
Zachariah Nazar ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Community Pharmacy ◽  
Lifestyle Intervention ◽  
Patient Reported Outcomes ◽  
Age Groups ◽  
Patient Activation ◽  
Prostate Cancer Treatment ◽  
Patient Reported ◽  
The Uk

Abstract Purpose To report patient activation, which is the knowledge, skills, and confidence in self-managing health conditions, and patient-reported outcomes of men after prostate cancer treatment from a community pharmacy lifestyle intervention. Methods The 3-month lifestyle intervention was delivered to 116 men in nine community pharmacies in the UK. Patient Activation Measure (PAM) was assessed at baseline, 3 and 6 months. Prostate cancer-related function and quality of life were assessed using the European Prostate Cancer Index Composite (EPIC-26) and EuroQOL 5-dimension 5-level (EQ5D-5L) questionnaires at baseline and 6 months. Lifestyle assessments included Mediterranean Diet Adherence Screener (MEDAS) at baseline, 3 and 6 months and Godin Leisure Time Exercise Questionnaire (GLTEQ) at baseline and 3 months. Results PAM score increased from 62 [95% CI 59–65] at baseline to 66 [64–69] after the intervention (p = 0.001) and remained higher at 6 months (p = 0.008). Scores for all the EPIC-26 domains (urinary, bowel and hormonal) were high at both assessments, indicating good function (between 74 [70–78] and 89 [86–91]), except sexual domain, where scores were much lower (21 [17–25] at baseline, increasing to 24 [20–28] at 6 months (p = 0.012)). In EQ5D-5L, 3% of men [1–9] reported self-care problems, while 50% [41–60] reported pain and discomfort, and no significant changes over time. Men who received androgen deprivation therapy, compared with those who did not, reported higher (better) urinary incontinence scores (p < 0.001), but lower (worse) scores in the urinary irritative/obstructive (p = 0.003), bowel (p < 0.001) and hormonal (p < 0.001) domains. Poor sexual function was common across all age groups irrespective of prostate cancer treatment. Conclusions The intervention led to significant improvements in patient activation, exercise and diet. Community pharmacy could deliver effective services to address sexual dysfunction, pain and discomfort which are common after prostate cancer.

Sign in / Sign up

Export Citation Format

Share Document